BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32726486)

  • 1. Hypoxia-inhibited miR-338-3p suppresses breast cancer progression by directly targeting ZEB2.
    He J; Wang J; Li S; Li T; Chen K; Zhang S
    Cancer Sci; 2020 Oct; 111(10):3550-3563. PubMed ID: 32726486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lnc NR2F1-AS1 Promotes Breast Cancer Metastasis by Targeting the MiR-25-3p/ZEB2 Axis.
    Zhai D; Zhou Y; Kuang X; Shao F; Zhen T; Lin Y; Wang Q; Shao N
    Int J Med Sci; 2023; 20(9):1152-1162. PubMed ID: 37575267
    [No Abstract]   [Full Text] [Related]  

  • 3. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
    Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
    Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-144-3p inhibited the growth, metastasis and epithelial-mesenchymal transition of colorectal adenocarcinoma by targeting ZEB1/2.
    Li T; Tang C; Huang Z; Yang L; Dai H; Tang B; Xiao B; Li J; Lei X
    Aging (Albany NY); 2021 Jul; 13(13):17349-17369. PubMed ID: 34226299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 6. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
    Sun G; Liu M; Han H
    J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulated lncRNA UCA1 acts as ceRNA to adsorb microRNA-498 to repress proliferation, invasion and epithelial mesenchymal transition of esophageal cancer cells by decreasing ZEB2 expression.
    Wang P; Liu X; Han G; Dai S; Ni Q; Xiao S; Huang J
    Cell Cycle; 2019 Sep; 18(18):2359-2376. PubMed ID: 31387451
    [No Abstract]   [Full Text] [Related]  

  • 8. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer.
    Ji H; Sang M; Liu F; Ai N; Geng C
    Pathol Res Pract; 2019 Apr; 215(4):697-704. PubMed ID: 30611621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer.
    Tang CP; Zhou HJ; Qin J; Luo Y; Zhang T
    Oncol Rep; 2017 Nov; 38(5):3144-3152. PubMed ID: 29048659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of hsa_circ_0004771 inhibits proliferation and induces apoptosis in breast cancer through activation of miR-653 by targeting ZEB2 signaling pathway.
    Xie R; Tang J; Zhu X; Jiang H
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30979827
    [No Abstract]   [Full Text] [Related]  

  • 11. MicroRNA-140 Represses Esophageal Cancer Progression via Targeting ZEB2 to Regulate Wnt/β-Catenin Pathway.
    Yang S; Li X; Shen W; Hu H; Li C; Han G
    J Surg Res; 2021 Jan; 257():267-277. PubMed ID: 32862055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-454-3p and miR-374b-5p suppress migration and invasion of bladder cancer cells through targetting ZEB2.
    Wang S; Zhang G; Zheng W; Xue Q; Wei D; Zheng Y; Yuan J
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30352837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.
    Wang JR; Liu B; Zhou L; Huang YX
    Cancer Biomark; 2019; 24(2):159-172. PubMed ID: 30614803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-138-5p suppresses lung adenocarcinoma cell epithelial-mesenchymal transition, proliferation and metastasis by targeting ZEB2.
    Zhu D; Gu L; Li Z; Jin W; Lu Q; Ren T
    Pathol Res Pract; 2019 May; 215(5):861-872. PubMed ID: 30712885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-325-3p Promotes the Proliferation, Invasion, and EMT of Breast Cancer Cells by Directly Targeting S100A2.
    Wang H; Hu X; Yang F; Xiao H
    Oncol Res; 2021 Sep; 28(7):731-744. PubMed ID: 33419488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIR-518a-5p Targets ZEB2 to Suppress the Migration and Invasion of Breast-cancer Cells.
    Wang L; Guo Z; Zhang S; Zhang X; Sang M; Liu Y; Shan B
    Altern Ther Health Med; 2023 Jan; 29(1):137-143. PubMed ID: 35986741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
    Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
    Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA SNHG3 promotes breast cancer cell proliferation and metastasis by binding to microRNA-154-3p and activating the notch signaling pathway.
    Jiang H; Li X; Wang W; Dong H
    BMC Cancer; 2020 Sep; 20(1):838. PubMed ID: 32883233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling.
    Huang N; Wu Z; Lin L; Zhou M; Wang L; Ma H; Xia J; Bin J; Liao Y; Liao W
    Oncotarget; 2015 Jun; 6(17):15222-34. PubMed ID: 25945841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer.
    Zhao XG; Hu JY; Tang J; Yi W; Zhang MY; Deng R; Mai SJ; Weng NQ; Wang RQ; Liu J; Zhang HZ; He JH; Wang HY
    Cell Death Dis; 2019 Jun; 10(7):479. PubMed ID: 31209222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.